Aprogen Biologics Inc. (003060.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−10.4x

Market Cap

KRW 22.86B

MomentumView details →

1D Return

−0.86%

YTD Return

−76.74%

RSI (14)

39.6

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−10.4x

Market Cap

KRW 22.86B

RSI (14)

39.6

MomentumView details →

1D Return

−0.86%

YTD Return

−76.74%

ProfitabilityView details →

Gross Margin

−27.08%

Net Margin

−90.85%

EBITDA Margin

−32.15%

ROE (TTM)

−40.31%

ROA (TTM)

−14.28%

Asset Turnover

0.15x

GrowthView details →

Revenue YoY

+26.13%

EPS YoY

+58.79%

FCF YoY

+36.64%

Revenue CAGR 3Y

+3.95%

EPS CAGR 3Y

−3.23%

EBITDA YoY

+82.43%

EarningsView details →

EPS (Actual)

−KRW 295.48

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

1.09x

Current Ratio

0.57x

Quick Ratio

0.35x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

86.18B

Net Income (TTM)

−78.30B

Op. CF (TTM)

−32.32B

Latest newsMore news →

No recent news for 003060.KS.

Similar companies

济川药业600566.SH 天士力600535.SH Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited00874.HK 华海药业600521.SH The United Laboratories International Holdings Limited03933.HK 哈药股份600664.SH Find similar companies →

Latest newsMore news →

No recent news for 003060.KS.